# Alpha Teknova, Inc.: filings

TKNO · Nasdaq · CIK 1850902 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/tkno.md) · [Financials](/companies/tkno/financials.md) · [Filings](/companies/tkno/filings.md) · [Insiders](/companies/tkno/insiders.md)

## Reports and events: 70 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 74, 8-K 39, 10-Q 16, 3 15, CORRESP 8, UPLOAD 6, 10-K 5, DEF 14A 5, EFFECT 5, S-8 5, 424B5 4, 4/A 4, ARS 4, DEFA14A 4, S-1 3, 424B3 2, D 2, S-3 2, SC 13G 2, SC 13G/A 2, SEC STAFF LETTER 2, 144 1, 424B4 1, 8-A12B 1, CERT 1, DEF 14C 1, DRS 1, DRS/A 1, DRSLTR 1, S-1/A 1, S-1MEF 1, SC 13D 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-21 | 20:41 ET | [8-K](/filings/0001193125-26-427930.md) | 1.01 Entry into a material agreement; 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-427930 |
| 2026-08-06 | 20:26 ET | [10-Q](/filings/0001193125-26-338178.md) | Quarterly report, period 2026-06-30 | 0001193125-26-338178 |
| 2026-08-05 | 20:06 ET | [8-K](/filings/0001193125-26-335059.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-335059 |
| 2026-06-01 | 21:22 ET | [8-K](/filings/0001850902-26-000011.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001850902-26-000011 |
| 2026-05-07 | 20:13 ET | [10-Q](/filings/0001850902-26-000008.md) | Quarterly report, period 2026-03-31 | 0001850902-26-000008 |
| 2026-05-06 | 20:11 ET | [8-K](/filings/0001850902-26-000007.md) | 2.02 Results of operations; 5.05 Item not in the standard list; 9.01 Financial statements and exhibits | 0001850902-26-000007 |
| 2026-04-21 | 21:22 ET | [DEF 14A](/filings/0001193125-26-167248.md) | Proxy statement, period 2026-04-21 | 0001193125-26-167248 |
| 2026-03-02 | 22:10 ET | [10-K](/filings/0001850902-26-000002.md) | Annual report, period 2025-12-31 | 0001850902-26-000002 |
| 2026-02-26 | 21:08 ET | [8-K](/filings/0001193125-26-076592.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-076592 |
| 2025-11-07 | 21:06 ET | [10-Q](/filings/0001193125-25-272321.md) | Quarterly report, period 2025-09-30 | 0001193125-25-272321 |
| 2025-11-06 | 21:08 ET | [8-K](/filings/0001193125-25-269488.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-269488 |
| 2025-08-08 | 20:07 ET | [10-Q](/filings/0000950170-25-105825.md) | Quarterly report, period 2025-06-30 | 0000950170-25-105825 |
| 2025-08-07 | 20:07 ET | [8-K](/filings/0000950170-25-105005.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-105005 |
| 2025-06-23 | 20:22 ET | [8-K](/filings/0000950170-25-089004.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000950170-25-089004 |
| 2025-05-09 | 20:17 ET | [10-Q](/filings/0000950170-25-068050.md) | Quarterly report, period 2025-03-31 | 0000950170-25-068050 |
| 2025-05-08 | 20:15 ET | [8-K](/filings/0000950170-25-067005.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-067005 |
| 2025-04-28 | 20:34 ET | [DEF 14A](/filings/0000950170-25-059353.md) | Proxy statement, period 2025-06-17 | 0000950170-25-059353 |
| 2025-03-07 | 22:30 ET | [10-K](/filings/0000950170-25-035705.md) | Annual report, period 2024-12-31 | 0000950170-25-035705 |
| 2025-03-04 | 21:08 ET | [8-K](/filings/0000950170-25-031995.md) | 1.01 Entry into a material agreement; 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-031995 |
| 2024-11-08 | 21:31 ET | [10-Q](/filings/0000950170-24-124159.md) | Quarterly report, period 2024-09-30 | 0000950170-24-124159 |
| 2024-11-07 | 21:14 ET | [8-K](/filings/0000950170-24-123359.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-123359 |
| 2024-08-23 | 20:52 ET | [S-1](/filings/0001193125-24-206239.md) | Registration statement | 0001193125-24-206239 |
| 2024-08-13 | 21:20 ET | [10-Q](/filings/0000950170-24-096441.md) | Quarterly report, period 2024-06-30 | 0000950170-24-096441 |
| 2024-08-13 | 20:08 ET | [8-K](/filings/0000950170-24-096188.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-096188 |
| 2024-07-19 | 20:11 ET | [SC 13D](/filings/0001193125-24-181644.md) | Ownership report, active investor | 0001193125-24-181644 |
| 2024-07-12 | 20:28 ET | [8-K](/filings/0000950170-24-083216.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-083216 |
| 2024-07-09 | 21:04 ET | [8-K](/filings/0000950170-24-082477.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-082477 |
| 2024-07-01 | 20:38 ET | [8-K](/filings/0000950170-24-079686.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-24-079686 |
| 2024-06-27 | 20:51 ET | [8-K](/filings/0000950170-24-078538.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000950170-24-078538 |
| 2024-05-13 | 21:09 ET | [10-Q](/filings/0000950170-24-058827.md) | Quarterly report, period 2024-03-31 | 0000950170-24-058827 |
| 2024-05-13 | 20:06 ET | [8-K](/filings/0000950170-24-058639.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-058639 |
| 2024-04-29 | 21:07 ET | [DEF 14A](/filings/0000950170-24-050038.md) | Proxy statement, period 2024-06-24 | 0000950170-24-050038 |
| 2024-04-02 | 21:51 ET | [8-K](/filings/0000950170-24-039576.md) | 4.01 Change of auditor | 0000950170-24-039576 |
| 2024-03-27 | 21:39 ET | [10-K](/filings/0000950170-24-036624.md) | Annual report, period 2023-12-31 | 0000950170-24-036624 |
| 2024-03-11 | 20:06 ET | [8-K](/filings/0000950170-24-029226.md) | 1.01 Entry into a material agreement; 2.02 Results of operations; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0000950170-24-029226 |
| 2024-01-16 | 22:15 ET | [8-K](/filings/0000950170-24-004716.md) | 2.05 Exit or disposal costs; 5.02 Departure or appointment of officers or directors | 0000950170-24-004716 |
| 2023-11-13 | 21:37 ET | [10-Q](/filings/0000950170-23-063053.md) | Quarterly report, period 2023-09-30 | 0000950170-23-063053 |
| 2023-11-09 | 21:06 ET | [8-K](/filings/0000950170-23-062023.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-062023 |
| 2023-10-25 | 20:39 ET | [S-1](/filings/0001193125-23-263115.md) | Registration statement | 0001193125-23-263115 |
| 2023-09-19 | 20:28 ET | [8-K](/filings/0001193125-23-237669.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-23-237669 |
| 2023-08-14 | 20:47 ET | [8-K](/filings/0000950170-23-042497.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-23-042497 |
| 2023-08-11 | 20:22 ET | [10-Q](/filings/0000950170-23-041875.md) | Quarterly report, period 2023-06-30 | 0000950170-23-041875 |
| 2023-08-10 | 20:09 ET | [8-K](/filings/0000950170-23-041316.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-041316 |
| 2023-07-10 | 21:23 ET | [8-K](/filings/0000950170-23-032403.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-23-032403 |
| 2023-06-20 | 11:00 ET | [8-K](/filings/0000950170-23-028767.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000950170-23-028767 |
| 2023-05-11 | 20:31 ET | [10-Q](/filings/0000950170-23-021313.md) | Quarterly report, period 2023-03-31 | 0000950170-23-021313 |
| 2023-05-10 | 20:05 ET | [8-K](/filings/0000950170-23-020499.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-020499 |
| 2023-04-28 | 20:30 ET | [DEF 14A](/filings/0000950170-23-015873.md) | Proxy statement, period 2023-06-13 | 0000950170-23-015873 |
| 2023-03-30 | 20:06 ET | [10-K](/filings/0000950170-23-010926.md) | Annual report, period 2022-12-31 | 0000950170-23-010926 |
| 2023-03-15 | 20:05 ET | [8-K](/filings/0000950170-23-008125.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-008125 |

Page 1 of 2. [Older](/companies/tkno/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:06 ET. No prices; not investment advice.